KRISTY GIERKE: Open Payments
NPI 1477902377 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 98 payments from 19 companies in 2025. Trend: 2023 $2,328 · 2024 $2,557 · 2025 $2,028
Food & beverage: $2,028
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $484 |
| Axsome Therapeutics, Inc. | 14 | $301 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $181 |
| Corium, LLC | 7 | $168 |
| Vanda Pharmaceuticals Inc. | 5 | $123 |
| Otsuka America Pharmaceutical, Inc. | 5 | $119 |
| Alkermes, Inc. | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. | 4 | $111 |
| Collegium Pharmaceutical, Inc. | 3 | $72 |
| Neos Therapeutics, LP | 3 | $71 |
Products named: VRAYLAR, Auvelity, CAPLYTA, Azstarys, FANAPT, ARISTADA, COBENFY, REXULTI.
Industry payments across GA — which companies pay providers there.
